CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-01 | Hillson Jan Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2023-02-01 | Gros David-Alexandre C Chief Executive Officer | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2023-02-01 | Gros David-Alexandre C Chief Executive Officer | Grant or award · Stock Option (right to buy) | +153,600 | 153,600 | ||
| 2023-02-01 | Smith Bryan E. General Counsel, Corporate Sec | Grant or award · Stock Option (right to buy) | +155,000 | 155,000 | ||
| 2023-02-01 | Little Paul Sean Chief Financial Officer | Grant or award · Stock Option (right to buy) | +155,000 | 155,000 | ||
| 2022-11-23 | Perrin Steven President | Purchase | +1,000 | $2.60 | $3K | 1,000 |
| 2022-02-01 | Gros David-Alexandre C Chief Executive Officer | Grant or award · Stock Option (right to buy) | +108,000 | 108,000 | ||
| 2022-02-01 | Smith Bryan E. General Counsel, Corporate Sec | Grant or award · Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2022-02-01 | Perrin Steven President | Grant or award · Stock Option (right to buy) | +155,000 | 155,000 | ||
| 2022-02-01 | Ogier Walter C Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-02-01 | McBride John S. Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-02-01 | LYONS GARY A Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-02-01 | Lee June Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-02-01 | Katkin Keith Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-02-01 | Hillson Jan Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-02-01 | Little Paul Sean Chief Financial Officer | Grant or award · Stock Option (right to buy) | +155,000 | 155,000 | ||
| 2021-12-20 | Gros David-Alexandre C Chief Executive Officer | Purchase | +2,000 | $4.48 | $9K | 9,000 |
| 2021-08-17 | Gros David-Alexandre C Chief Executive Officer | Purchase | +4,000 | $6.21 | $25K | 7,000 |
| 2021-06-11 | Little Paul Sean CHIEF FINANCIAL OFFICER | Purchase | +10,000 | $8.87 | $89K | 10,000 |
| 2021-06-09 | Gros David-Alexandre C Chief Executive Officer | Purchase | +3,000 | $8.01 | $24K | 3,000 |
Page 5 of 15 · 300 trades